Babar, Zara, and Areesha Babar. “FDA’s New Approval: Kisunla (Donanemab-Azbt) - A Major Breakthrough in Alzheimer’s Care”. Journal of the Pakistan Medical Association 75, no. 07 (July 1, 2025): 1156–1156. Accessed June 17, 2026. https://www.jpma.org.pk/index.php/public_html/article/view/21951.